Global Neurodegenerative Diseases Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID :QYR-14116295 | Published Date: 18-Apr-2019 | No. of pages: 147Description
TOC
Table of Contents
1 Neurodegenerative Diseases Market Overview
1.1 Neurodegenerative Diseases Product Overview
1.2 Neurodegenerative Diseases Market Segment by Type
1.2.1 NMDA
1.2.2 SSRIs
1.2.3 Dopamine Inhibitors
1.3 Global Neurodegenerative Diseases Market Size by Type
1.3.1 Global Neurodegenerative Diseases Sales and Growth by Type
1.3.2 Global Neurodegenerative Diseases Sales and Market Share by Type (2014-2019)
1.3.3 Global Neurodegenerative Diseases Revenue and Market Share by Type (2014-2019)
1.3.4 Global Neurodegenerative Diseases Price by Type (2014-2019)
2 Global Neurodegenerative Diseases Market Competition by Company
2.1 Global Neurodegenerative Diseases Sales and Market Share by Company (2014-2019)
2.2 Global Neurodegenerative Diseases Revenue and Share by Company (2014-2019)
2.3 Global Neurodegenerative Diseases Price by Company (2014-2019)
2.4 Global Top Players Neurodegenerative Diseases Manufacturing Base Distribution, Sales Area, Product Types
2.5 Neurodegenerative Diseases Market Competitive Situation and Trends
2.5.1 Neurodegenerative Diseases Market Concentration Rate
2.5.2 Global Neurodegenerative Diseases Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Neurodegenerative Diseases Company Profiles and Sales Data
3.1 Novartis
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Neurodegenerative Diseases Product Category, Application and Specification
3.1.3 Novartis Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Merck Serono
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Neurodegenerative Diseases Product Category, Application and Specification
3.2.3 Merck Serono Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Teva Pharmaceutical
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Neurodegenerative Diseases Product Category, Application and Specification
3.3.3 Teva Pharmaceutical Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 UCB
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Neurodegenerative Diseases Product Category, Application and Specification
3.4.3 UCB Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Pfizer
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Neurodegenerative Diseases Product Category, Application and Specification
3.5.3 Pfizer Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Biogen Idec
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Neurodegenerative Diseases Product Category, Application and Specification
3.6.3 Biogen Idec Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Bayer Schering Pharma AG
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Neurodegenerative Diseases Product Category, Application and Specification
3.7.3 Bayer Schering Pharma AG Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Boehringer Ingelheim
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Neurodegenerative Diseases Product Category, Application and Specification
3.8.3 Boehringer Ingelheim Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Addex Pharmaceutical
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Neurodegenerative Diseases Product Category, Application and Specification
3.9.3 Addex Pharmaceutical Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Amarin
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Neurodegenerative Diseases Product Category, Application and Specification
3.10.3 Amarin Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 AstraZeneca
3.12 Asubio Pharmaceutical
3.13 Bial
3.14 Alector
3.15 Yumanity Therapeutics
3.16 Eisai
3.17 H.Lundbeck A/S
3.18 Jiangsu Hansoh Pharmaceutical
3.19 Yangtze River Pharmaceutical Group
3.20 Chongqing Zein Pharmaceutical
4 Neurodegenerative Diseases Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Neurodegenerative Diseases Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Neurodegenerative Diseases Sales and Revenue by Regions
4.2.1 Global Neurodegenerative Diseases Sales and Market Share by Regions (2014-2019)
4.2.2 Global Neurodegenerative Diseases Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Neurodegenerative Diseases Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Neurodegenerative Diseases Application/End Users
5.1 Neurodegenerative Diseases Segment by Application
5.1.1 Parkinson’s disease
5.1.2 Huntington disease
5.1.3 Amyotrophic Lateral Sclerosis
5.1.4 Alzheimer’s disease
5.2 Global Neurodegenerative Diseases Product Segment by Application
5.2.1 Global Neurodegenerative Diseases Sales by Application
5.2.2 Global Neurodegenerative Diseases Sales and Market Share by Application (2014-2019)
6 Global Neurodegenerative Diseases Market Forecast
6.1 Global Neurodegenerative Diseases Sales, Revenue Forecast (2019-2025)
6.1.1 Global Neurodegenerative Diseases Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Neurodegenerative Diseases Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Neurodegenerative Diseases Forecast by Regions
6.2.1 North America Neurodegenerative Diseases Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Neurodegenerative Diseases Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Neurodegenerative Diseases Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Neurodegenerative Diseases Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Neurodegenerative Diseases Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Neurodegenerative Diseases Forecast by Type
6.3.1 Global Neurodegenerative Diseases Sales and Revenue Forecast by Type (2019-2025)
6.3.2 NMDA Gowth Forecast
6.3.3 SSRIs Gowth Forecast
6.4 Neurodegenerative Diseases Forecast by Application
6.4.1 Global Neurodegenerative Diseases Sales Forecast by Application (2019-2025)
6.4.2 Global Neurodegenerative Diseases Forecast in Parkinson’s disease
6.4.3 Global Neurodegenerative Diseases Forecast in Huntington disease
7 Neurodegenerative Diseases Upstream Raw Materials
7.1 Neurodegenerative Diseases Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Neurodegenerative Diseases Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
Tables & Figures
List of Tables and Figures
Figure Neurodegenerative Diseases Product Picture
Figure Global Neurodegenerative Diseases Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Neurodegenerative Diseases Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of NMDA
Table Major Players of NMDA
Figure Global NMDA Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of SSRIs
Table Major Players of SSRIs
Figure Global SSRIs Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Dopamine Inhibitors
Table Major Players of Dopamine Inhibitors
Figure Global Dopamine Inhibitors Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Neurodegenerative Diseases Sales (K Units) by Type (2014-2019)
Table Global Neurodegenerative Diseases Sales Share (%) by Type (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share (%) by Type (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share (%) by Type in 2018
Table Global Neurodegenerative Diseases Revenue (Million USD) by Type (2014-2019)
Table Global Neurodegenerative Diseases Revenue Share (%) by Type (2014-2019)
Figure Global Neurodegenerative Diseases Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Neurodegenerative Diseases Revenue Market Share (%) by Type
Table Global Neurodegenerative Diseases Price (USD/Unit) by Type (2014-2019)
Table Global Neurodegenerative Diseases Sales (K Units) by Company (2014-2019)
Table Global Neurodegenerative Diseases Sales Share (%) by Company (2014-2019)
Figure Global Neurodegenerative Diseases Sales Share (%) by Company in 2018
Table Global Neurodegenerative Diseases Revenue (Million USD) by Company (2014-2019)
Table Global Neurodegenerative Diseases Revenue Share (%) by Company (2014-2019)
Figure Global Neurodegenerative Diseases Revenue Share (%) by Company in 2018
Table Global Market Neurodegenerative Diseases Average Price (USD/Unit) by Company (2014-2019)
Table Global Neurodegenerative Diseases Top Players Manufacturing Base Distribution and Sales Area
Table Global Neurodegenerative Diseases Top Players Product Category
Figure Global Neurodegenerative Diseases Market Share (%) of Top 5 Players
Figure Global Neurodegenerative Diseases Market Share (%) of Top 10 Players
Table Novartis Basic Information List
Table Novartis Neurodegenerative Diseases Product Category, Application and Specification
Table Novartis Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Novartis Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Novartis Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table Merck Serono Basic Information List
Figure Merck Serono Neurodegenerative Diseases Product Category, Application and Specification
Table Merck Serono Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Merck Serono Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Merck Serono Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table Teva Pharmaceutical Basic Information List
Figure Teva Pharmaceutical Neurodegenerative Diseases Product Category, Application and Specification
Table Teva Pharmaceutical Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Teva Pharmaceutical Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Teva Pharmaceutical Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table UCB Basic Information List
Figure UCB Neurodegenerative Diseases Product Category, Application and Specification
Table UCB Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure UCB Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure UCB Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table Pfizer Basic Information List
Figure Pfizer Neurodegenerative Diseases Product Category, Application and Specification
Table Pfizer Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Pfizer Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table Biogen Idec Basic Information List
Figure Biogen Idec Neurodegenerative Diseases Product Category, Application and Specification
Table Biogen Idec Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Biogen Idec Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Biogen Idec Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table Bayer Schering Pharma AG Basic Information List
Figure Bayer Schering Pharma AG Neurodegenerative Diseases Product Category, Application and Specification
Table Bayer Schering Pharma AG Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bayer Schering Pharma AG Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Bayer Schering Pharma AG Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table Boehringer Ingelheim Basic Information List
Figure Boehringer Ingelheim Neurodegenerative Diseases Product Category, Application and Specification
Table Boehringer Ingelheim Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Boehringer Ingelheim Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Boehringer Ingelheim Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table Addex Pharmaceutical Basic Information List
Figure Addex Pharmaceutical Neurodegenerative Diseases Product Category, Application and Specification
Table Addex Pharmaceutical Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Addex Pharmaceutical Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Addex Pharmaceutical Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table Amarin Basic Information List
Figure Amarin Neurodegenerative Diseases Product Category, Application and Specification
Table Amarin Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Amarin Neurodegenerative Diseases Sales Growth Rate (2014-2019)
Figure Amarin Neurodegenerative Diseases Sales Global Market Share (%)(2014-2019)
Table AstraZeneca Basic Information List
Table Asubio Pharmaceutical Basic Information List
Table Bial Basic Information List
Table Alector Basic Information List
Table Yumanity Therapeutics Basic Information List
Table Eisai Basic Information List
Table H.Lundbeck A/S Basic Information List
Table Jiangsu Hansoh Pharmaceutical Basic Information List
Table Yangtze River Pharmaceutical Group Basic Information List
Table Chongqing Zein Pharmaceutical Basic Information List
Table Global Neurodegenerative Diseases Market Size Comparison by Regions (2014-2025)
Figure North America Neurodegenerative Diseases Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Neurodegenerative Diseases Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Neurodegenerative Diseases Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Neurodegenerative Diseases Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Neurodegenerative Diseases Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Neurodegenerative Diseases Sales (K Units) by Regions (2014-2019)
Table Global Neurodegenerative Diseases Sales Market Share (%) by Regions (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Neurodegenerative Diseases Sales Market Share (%) by Regions
Table Global Neurodegenerative Diseases Revenue (Million USD) by Regions (2014-2019)
Table Global Neurodegenerative Diseases Revenue Market Share (%) by Regions (2014-2019)
Figure Global Neurodegenerative Diseases Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Neurodegenerative Diseases Revenue Market Share (%) by Regions
Table Global Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Neurodegenerative Diseases Sales Growth Rate
Table North America Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure United States Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Canada Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Canada Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Mexico Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Mexico Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Europe Neurodegenerative Diseases Sales Growth Rate
Table Europe Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Germany Neurodegenerative Diseases Revenue (Million USD) (2014-2019)
Figure UK Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure UK Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure France Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure France Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Italy Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Italy Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Russia Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Russia Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Turkey Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Turkey Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Neurodegenerative Diseases Sales Growth Rate
Table Asia-Pacific Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure China Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Japan Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Japan Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Korea Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Korea Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Southeast Asia Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Southeast Asia Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Indonesia Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Indonesia Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Thailand Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Thailand Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Malaysia Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Malaysia Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Philippines Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Philippines Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Vietnam Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Vietnam Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure India Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure India Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Australia Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Australia Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure South America Neurodegenerative Diseases Sales Growth Rate
Table South America Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure Brazil Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Neurodegenerative Diseases Sales Growth Rate
Table Middle East and Africa Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure North Africa Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure GCC Countries Neurodegenerative Diseases Sales (K Units)(2014-2019)
Figure GCC Countries Neurodegenerative Diseases Revenue (Million USD)(2014-2019)
Figure Parkinson’s disease Examples
Figure Huntington disease Examples
Figure Amyotrophic Lateral Sclerosis Examples
Figure Alzheimer’s disease Examples
Table Global Neurodegenerative Diseases Sales (K Units) Comparison by Application (2014-2025)
Table Global Neurodegenerative Diseases Sales (K Units) by Application (2014-2019)
Table Global Neurodegenerative Diseases Sales Share (%) by Application (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share (%) by Application (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share (%) by Application in 2018
Figure Global Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Neurodegenerative Diseases Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Neurodegenerative Diseases Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Neurodegenerative Diseases Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Neurodegenerative Diseases Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Neurodegenerative Diseases Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Neurodegenerative Diseases Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Neurodegenerative Diseases Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Neurodegenerative Diseases Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Neurodegenerative Diseases Revenue Market Share (%) Forecast by Type (2019-2025)
Figure NMDA Sales Growth Forecast
Figure SSRIs Sales Growth Forecast
Table Global Neurodegenerative Diseases Sales (K Units) Forecast by Application (2019-2025)
Figure Global Neurodegenerative Diseases Sales Forecast by Application (2019-2025)
Figure Global Neurodegenerative Diseases Sales (K Units) Forecast in Parkinson’s disease
Figure Global Neurodegenerative Diseases Sales (K Units) Forecast in Huntington disease
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Neurodegenerative Diseases Manufacturing Cost Structure
Figure Neurodegenerative Diseases Industrial Chain Analysis
Table Distributors List
Table Neurodegenerative Diseases Downstream Customers
Companies
Novartis
Merck Serono
Teva Pharmaceutical
UCB
Pfizer
Biogen Idec
Bayer Schering Pharma AG
Boehringer Ingelheim
Addex Pharmaceutical
Amarin
AstraZeneca
Asubio Pharmaceutical
Bial
Alector
Yumanity Therapeutics
Eisai
H.Lundbeck A/S
Jiangsu Hansoh Pharmaceutical
Yangtze River Pharmaceutical Group
Chongqing Zein Pharmaceutical
- PRICE
-
$3350$6700$5025Buy Now